An inhibitor of TG2
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

ZED-1227

Item No. 42333

Technical Information
Formal Name
(2E,6S)-7-[[1-[2-[(2-ethylbutyl)amino]-2-oxoethyl]-1,2-dihydro-2-oxo-3-pyridinyl]amino]-6-[[(1-methyl-1H-imidazol-5-yl)carbonyl]amino]-7-oxo-2-heptenoic acid, methyl ester
CAS Number
1542132-88-6
Synonyms
  • TAK-227
Molecular Formula
C26H36N6O6
Formula Weight
Purity
≥95%
A solid
DMSO: Slightly soluble: 0.1-1 mg/ml
SMILES
O=C([C@@H](NC(C1=CN=CN1C)=O)CC/C=C/C(OC)=O)NC2=CC=CN(CC(NCC(CC)CC)=O)C2=O
InChi Code
InChI=1S/C26H36N6O6/c1-5-18(6-2)14-28-22(33)16-32-13-9-11-20(26(32)37)30-24(35)19(10-7-8-12-23(34)38-4)29-25(36)21-15-27-17-31(21)3/h8-9,11-13,15,17-19H,5-7,10,14,16H2,1-4H3,(H,28,33)(H,29,36)(H,30,35)/b12-8+/t19-/m0/s1
InChi Key
VHGWUSABWIEXKQ-BEBFYNPSSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    ZED-1227 is an inhibitor of transglutaminase 2 (TG2; IC50 = 0.053 µM).1 It is selective for TG2 over TG1, TG3, TG6, and Factor XIIIa2 (IC50s = 24.86, >50, 6.44, and >50 µM, respectively). ZED-1227 (25 and 50 mg/kg) increases the duodenal villous height-to-crypt depth ratio and reduces the percentage of CD3+ duodenal intraepithelial lymphocytes and CD138+ duodenal plasma cells in a humanized mouse model of celiac disease.2 It also increases duodenal expression of Tgfb1, Aldh1a2, and other genes associated with regulatory immune responses and epithelial adaptation in the same model.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Büchold, C., Hils, M., Gerlach, U., et al. Features of ZED1227: The first-in-class tissue transglutaminase inhibitor undergoing clinical evaluation for the treatment of celiac disease. Cells 11(10), 1667 (2022).

    2. Pesi, A., Encalada-Ventura, M.A., Mard, H.E.L., et al. A humanized celiac disease mouse model reflects histologic and immune effects of transglutaminase inhibition in patients. Gastroenterolgy (2026).